Hye In Woo

476 total citations
24 papers, 346 citations indexed

About

Hye In Woo is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Surgery. According to data from OpenAlex, Hye In Woo has authored 24 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 5 papers in Infectious Diseases and 4 papers in Surgery. Recurrent topics in Hye In Woo's work include Acute Lymphoblastic Leukemia research (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Hormonal Regulation and Hypertension (3 papers). Hye In Woo is often cited by papers focused on Acute Lymphoblastic Leukemia research (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Hormonal Regulation and Hypertension (3 papers). Hye In Woo collaborates with scholars based in South Korea, United States and Japan. Hye In Woo's co-authors include Soo‐Youn Lee, Hyung‐Doo Park, Rihwa Choi, Kyung‐Hoon Lee, Jae Hyeon Kim, Yoon Young Cho, Jeong Soo Yang, Hong Hoe Koo, Jae‐Wook Ko and Wooseong Huh and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Emerging infectious diseases.

In The Last Decade

Hye In Woo

23 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hye In Woo South Korea 12 101 66 58 56 51 24 346
Gopal S Pillai India 10 43 0.4× 48 0.7× 66 1.1× 51 0.9× 42 0.8× 36 349
Virginie Gualano France 10 70 0.7× 21 0.3× 64 1.1× 47 0.8× 46 0.9× 22 394
Helen Gu United States 12 54 0.5× 75 1.1× 112 1.9× 49 0.9× 31 0.6× 19 507
M Weiss United States 13 117 1.2× 29 0.4× 95 1.6× 37 0.7× 31 0.6× 25 465
Saeed Rezaee Iran 12 32 0.3× 31 0.5× 81 1.4× 31 0.6× 19 0.4× 43 433
Kathleen M. Heinz-Taheny United States 9 80 0.8× 88 1.3× 121 2.1× 30 0.5× 9 0.2× 18 354
Azra Hussaini United States 10 44 0.4× 63 1.0× 38 0.7× 12 0.2× 30 0.6× 14 258
René Vos Netherlands 11 39 0.4× 36 0.5× 53 0.9× 9 0.2× 41 0.8× 16 334
Steven R. Binder United States 18 43 0.4× 60 0.9× 147 2.5× 64 1.1× 18 0.4× 37 763
Pasi Koskimies Finland 17 189 1.9× 92 1.4× 219 3.8× 83 1.5× 25 0.5× 27 867

Countries citing papers authored by Hye In Woo

Since Specialization
Citations

This map shows the geographic impact of Hye In Woo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hye In Woo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hye In Woo more than expected).

Fields of papers citing papers by Hye In Woo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hye In Woo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hye In Woo. The network helps show where Hye In Woo may publish in the future.

Co-authorship network of co-authors of Hye In Woo

This figure shows the co-authorship network connecting the top 25 collaborators of Hye In Woo. A scholar is included among the top collaborators of Hye In Woo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hye In Woo. Hye In Woo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Chanhee, Hyung Suk Kim, H. Kwon, et al.. (2025). Complementary Multi‐Resonance Thermally Activated Delayed Fluorescence Design for Blue OLEDs Beyond the Concentration Limit. Angewandte Chemie International Edition. 65(7). e19657–e19657.
2.
Woo, Hye In, et al.. (2021). Alteration of transthyretin and thyroxine-binding globulin in major depressive disorder: multiple reaction monitoring-based proteomic analysis. Journal of Translational Medicine. 19(1). 34–34. 4 indexed citations
3.
Choi, Rihwa, Hye In Woo, Hyung‐Doo Park, & Soo‐Youn Lee. (2019). <p>A nationwide utilization survey of therapeutic drug monitoring for five antibiotics in South Korea</p>. Infection and Drug Resistance. Volume 12. 2163–2173. 15 indexed citations
4.
Lee, Kyung‐Hoon, Rihwa Choi, Hye In Woo, et al.. (2019). Therapeutic drug monitoring of teicoplanin using an LC–MS/MS method: Analysis of 421 measurements in a naturalistic clinical setting. Journal of Pharmaceutical and Biomedical Analysis. 167. 161–165. 11 indexed citations
5.
Lee, Kyung‐Hoon, et al.. (2019). Experience with therapeutic drug monitoring of three antifungal agents using an LC-MS/MS method in routine clinical practice. Clinical Biochemistry. 70. 14–17. 18 indexed citations
6.
Son, Ki Young, et al.. (2019). Ocular Manifestations, Treatment Outcome and Clinical Course of Infective Keratitis of Keratitis-Ichthyosis-Deafness Syndrome. Journal of the Korean Ophthalmological Society. 60(12). 1323–1323. 1 indexed citations
7.
Lee, Kyung‐Hoon, et al.. (2018). Evaluation of Stability of Thiopurine Metabolites Using a Validated LC-MS/MS Method. Annals of Laboratory Medicine. 38(3). 255–260. 15 indexed citations
8.
Woo, Hye In, et al.. (2017). Association of genetic variations with pharmacokinetics and lipid-lowering response to atorvastatin in healthy Korean subjects. Drug Design Development and Therapy. Volume11. 1135–1146. 26 indexed citations
9.
Lee, Ji Hyeon, Tae Jun Kim, Eun Ran Kim, et al.. (2017). Measurements of 6-thioguanine nucleotide levels with TPMT and NUDT15 genotyping in patients with Crohn’s disease. PLoS ONE. 12(12). e0188925–e0188925. 25 indexed citations
10.
11.
Wi, Yu Mi, Hye In Woo, Dahee Park, et al.. (2016). Severe Fever with Thrombocytopenia Syndrome in Patients Suspected of Having Scrub Typhus. Emerging infectious diseases. 22(11). 1992–1995. 22 indexed citations
12.
13.
Jung, Yu Jung, Hye In Woo, Kyeongman Jeon, et al.. (2015). The Significance of Sensitive Interferon Gamma Release Assays for Diagnosis of Latent Tuberculosis Infection in Patients Receiving Tumor Necrosis Factor-α Antagonist Therapy. PLoS ONE. 10(10). e0141033–e0141033. 15 indexed citations
14.
Lee, Kyung‐Hoon, et al.. (2014). How to Use Warfarin Assays in Patient Management: Analysis of 437 Warfarin Measurements in a Clinical Setting. Clinical Pharmacokinetics. 54(5). 517–525. 4 indexed citations
15.
16.
Jang, Mi‐Ae, Hye In Woo, Jong‐Won Kim, Jeehun Lee, & Chang‐Seok Ki. (2013). Identification of DCX Gene Mutation in Lissencephaly Spectrum With Subcortical Band Heterotopia Using Whole Exome Sequencing. Pediatric Neurology. 48(5). 411–414. 7 indexed citations
17.
Woo, Hye In, et al.. (2012). Simultaneous analysis of 17 diuretics in dietary supplements by HPLC and LC-MS/MS. Food Additives & Contaminants Part A. 30(2). 209–217. 41 indexed citations
18.
Woo, Hye In, Hangseok Choi, Seonwoo Kim, et al.. (2012). Effect of Genetic Polymorphisms on Therapeutic Response and Clinical Outcomes in Pancreatic Cancer Patients Treated with Gemcitabine. Pharmacogenomics. 13(9). 1023–1035. 16 indexed citations
19.
Woo, Hye In, et al.. (2012). Combined congenital dysfibrinogenemia and factor VII deficiency from mutations in the FGB and F7 genes. Blood Coagulation & Fibrinolysis. 23(5). 355–358. 6 indexed citations
20.
Woo, Hye In, Jang Ho Lee, Seung‐Tae Lee, Chang‐Seok Ki, & Nam Yong Lee. (2010). Catheter-related Bacteremia due toMicrobacterium oxydansIdentified by 16S rRNA Sequencing Analysis and Biochemical Characteristics. Korean Journal of Clinical Microbiology. 13(4). 173–173. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gopal S Pillai Breakdown of academic impact, for papers by Virginie Gualano Breakdown of academic impact, for papers by Helen Gu Breakdown of academic impact, for papers by M Weiss Breakdown of academic impact, for papers by Saeed Rezaee Breakdown of academic impact, for papers by Kathleen M. Heinz-Taheny Breakdown of academic impact, for papers by Azra Hussaini Breakdown of academic impact, for papers by René Vos Breakdown of academic impact, for papers by Steven R. Binder Breakdown of academic impact, for papers by Pasi Koskimies
Rankless by CCL
2026